WHIN
Venture capitalActively deployingNew York
Fund manager profile
WHIN is a venture fund manager based in New York. SEC filings show 2 venture funds on record, most recently WHIN Opportunity Fund, LP filed September 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Digital Health ×1Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathAllyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Jennifer Gabler(Executive Officer)Robert A. Bettigole(Director)Paul Fonteyne(Co-Founder)Gregory P. Ho(Director)Stephen Strittmatter(Scientific Founder)Stephen Bloch(CEO, Co-Founder)
Board seatGregory P HoGregory P. Ho· per SEC Form D · $30M raise · filed May 2026
BiotechBrooklyn, US
Jason Rifkin(Director)Surajit Dhara(Executive Officer, Director)Gregory P. Ho(Director)Robert Warren(Director)
Board seatGregory P. Ho· per SEC Form D · $2.5M raise · filed Mar 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- Where is WHIN located?
- WHIN is headquartered in New York, US.